These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29223469)

  • 1. Oncological and functional outcomes of elderly men treated with HIFU vs. minimally invasive radical prostatectomy: A propensity score analysis.
    Capogrosso P; Barret E; Sanchez-Salas R; Nunes-Silva I; Rozet F; Galiano M; Ventimiglia E; Briganti A; Salonia A; Montorsi F; Cathelineau X
    Eur J Surg Oncol; 2018 Jan; 44(1):185-191. PubMed ID: 29223469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peri-operative, functional and early oncologic outcomes of salvage robotic-assisted radical prostatectomy after high-intensity focused ultrasound partial ablation.
    Thompson JE; Sridhar AN; Shaw G; Rajan P; Mohammed A; Briggs TP; Nathan S; Kelly JD; Sooriakumaran P
    BMC Urol; 2020 Jul; 20(1):81. PubMed ID: 32611411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes.
    Devos B; Al Hajj Obeid W; Andrianne C; Diamand R; Peltier A; Everaerts W; Van Poppel H; Van Velthoven R; Joniau S
    World J Urol; 2019 Aug; 37(8):1507-1515. PubMed ID: 30666400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis.
    Albisinni S; Aoun F; Bellucci S; Biaou I; Limani K; Hawaux E; Peltier A; van Velthoven R
    J Endourol; 2017 Jan; 31(1):14-19. PubMed ID: 27799004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
    Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
    Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage high-intensity focused ultrasound for locally recurrent prostate cancer after low-dose-rate brachytherapy: oncological and functional outcomes.
    Hostiou T; Gelet A; Chapelon JY; Rouvière O; Mège-Lechevalier F; Lafon C; Tonoli-Catez H; Badet L; Crouzet S
    BJU Int; 2019 Nov; 124(5):746-757. PubMed ID: 31148367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Analysis of Partial Gland Ablation and Radical Prostatectomy to Treat Low and Intermediate Risk Prostate Cancer: Oncologic and Functional Outcomes.
    Garcia-Barreras S; Sanchez-Salas R; Sivaraman A; Barret E; Secin F; Nunes-Silva I; Linares-Espinós E; Rozet F; Galiano M; Cathelineau X
    J Urol; 2018 Jan; 199(1):140-146. PubMed ID: 28823768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of Oncological and Functional Outcomes Between Primary Whole-Gland Cryoablation and High-Intensity Focused Ultrasound for Localized Prostate Cancer.
    Liu YY; Chiang PH
    Ann Surg Oncol; 2016 Jan; 23(1):328-34. PubMed ID: 26088651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological long-term outcome of whole gland HIFU and open radical prostatectomy: a comparative analysis.
    Rosenhammer B; Ganzer R; Zeman F; Näger T; Fritsche HM; Blana A; Burger M; Bründl J
    World J Urol; 2019 Oct; 37(10):2073-2080. PubMed ID: 30603784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological Long-term Outcome After Whole-gland High-intensity Focused Ultrasound for Prostate Cancer-21-yr Follow-up.
    Bründl J; Osberghaus V; Zeman F; Breyer J; Ganzer R; Blana A; Gierth M; Denzinger S; Burger M; Rosenhammer B
    Eur Urol Focus; 2022 Jan; 8(1):134-140. PubMed ID: 33483288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
    Pfeiffer D; Berger J; Gross AJ
    BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer.
    Pierorazio PM; Mullins JK; Eifler JB; Voth K; Hyams ES; Han M; Pavlovich CP; Bivalacqua TJ; Partin AW; Allaf ME; Schaeffer EM
    BJU Int; 2013 Oct; 112(6):751-7. PubMed ID: 23356390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study.
    Clery R; Grande P; Seisen T; Gobert A; Duquesne I; Villers A; Olivier J; Bernhard JC; Robert G; Beauval JB; Prudhomme T; Bruyère F; Lainé-Caroff P; Waltregny D; Guillonneau B; Panarello D; Ruffion A; De Bayser H; de La Taille A; Roupret M
    World J Urol; 2019 Aug; 37(8):1491-1498. PubMed ID: 30790014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Whole-Gland High-Intensity Focused Ultrasound vs Whole-Gland High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: 1-Year Oncological and Functional Outcomes.
    Lei Y; Zanker P; Yildiz S; Hancke K; Seidl D; Koch O; Schwentner C; Mundhenk J
    J Endourol; 2019 Feb; 33(2):100-106. PubMed ID: 30526029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer.
    van Velthoven R; Aoun F; Marcelis Q; Albisinni S; Zanaty M; Lemort M; Peltier A; Limani K
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):79-83. PubMed ID: 26597660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Focal HIFU vs robot-assisted total prostatectomy: Functionnal and oncologic outcomes at one year].
    Arnouil N; Gelet A; Matillon X; Rouviere O; Colombel M; Ruffion A; Mège-Lechevallier F; Subtil F; Badet L; Crouzet S
    Prog Urol; 2018 Oct; 28(12):603-610. PubMed ID: 30243461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort.
    Dickinson L; Arya M; Afzal N; Cathcart P; Charman SC; Cornaby A; Hindley RG; Lewi H; McCartan N; Moore CM; Nathan S; Ogden C; Persad R; van der Meulen J; Weir S; Emberton M; Ahmed HU
    Eur Urol; 2016 Oct; 70(4):668-674. PubMed ID: 26951947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?
    Lee HW; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY
    J Korean Med Sci; 2015 Nov; 30(11):1631-7. PubMed ID: 26539008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.